Skip to main content
Clinical Trials/JPRN-jRCT2031210589
JPRN-jRCT2031210589Active, not recruiting未知

A special drug use-results survey to evaluate the safety and efficacy of subcutaneous administration of Cosentyx in pediatric patients with psoriasis vulgaris, psoriatic arthritis, or pustular psoriasis

Toshiya Sugimoto0 sites35 target enrollmentStarted: January 31, 2022Last updated:

Trial Snapshot

Phase
未知
Status
Active, not recruiting
Sponsor
Enrollment
35

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
ot applicable to < 18age old (—)
Sex
All

Inclusion Criteria

  • 1.Patients who have obtained written consent from their legally acceptable representative to cooperate in this survey before the start of treatment with this drug
  • 2.Patients aged less than 18 years at the start of treatment with this drug
  • 3.Patients newly treated with this drug for any of the following diseases: Psoriasis vulgaris, psoriatic arthritis, pustular psoriasis

Exclusion Criteria

  • 1.Prior treatment with this drug
  • 2.Participation in an interventional study (e.g., a clinical trial) at the time of starting this drug.

Investigators

Sponsor
Toshiya Sugimoto

Similar Trials